<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28827845</article-id><article-id pub-id-type="pmc">5565178</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0183584</article-id><article-id pub-id-type="publisher-id">PONE-D-17-01924</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Cardiology</subject><subj-group><subject>Myocardial Infarction</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Cardiovascular Anatomy</subject><subj-group><subject>Heart</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Cardiovascular Anatomy</subject><subj-group><subject>Heart</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Cardiovascular Anatomy</subject><subj-group><subject>Heart</subject><subj-group><subject>Myocardium</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Cardiovascular Anatomy</subject><subj-group><subject>Heart</subject><subj-group><subject>Myocardium</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune Physiology</subject><subj-group><subject>Spleen</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune Physiology</subject><subj-group><subject>Spleen</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune Physiology</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune Physiology</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System</subject><subj-group><subject>Innate Immune System</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System</subject><subj-group><subject>Innate Immune System</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Developmental Biology</subject><subj-group><subject>Molecular Development</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Blood Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>T Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>T Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>T Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>T Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System</subject><subj-group><subject>Thymus</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System</subject><subj-group><subject>Thymus</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene Expression</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>ROR&#x003b3;t-expressing cells attenuate cardiac remodeling after myocardial infarction</article-title><alt-title alt-title-type="running-head">Protective roles of ROR&#x003b3;t-expressing cells</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Enomoto</surname><given-names>Daichi</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Matsumoto</surname><given-names>Kotaro</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Yamashita</surname><given-names>Tomomi</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Kobayashi</surname><given-names>Arisa</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Maeda</surname><given-names>Makiko</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Nakayama</surname><given-names>Hiroyuki</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3209-2208</contrib-id><name><surname>Obana</surname><given-names>Masanori</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="corresp" rid="cor001">*</xref><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Fujio</surname><given-names>Yasushi</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"/></contrib></contrib-group><aff id="aff001"><addr-line>Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Frangogiannis</surname><given-names>Nikolaos</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Albert Einstein College of Medicine, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>obana@phs.osaka-u.ac.jp</email></corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>12</volume><issue>8</issue><elocation-id>e0183584</elocation-id><history><date date-type="received"><day>15</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>6</day><month>8</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 Enomoto et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Enomoto et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0183584.pdf"/><abstract><sec id="sec001"><title>Aims</title><p>Retinoic acid receptor-related orphan nuclear receptor &#x003b3;t (ROR&#x003b3;t) is a transcriptional factor responsible for IL-17-producing T-cell differentiation. Although it was demonstrated that ROR&#x003b3;t plays essential roles in the onset of autoimmune myocarditis, pathophysiological significance of ROR&#x003b3;t in cardiac remodeling after myocardial infarction (MI) remains to be fully elucidated.</p></sec><sec id="sec002"><title>Methods and results</title><p>MI was generated by ligating coronary artery. The expression of ROR&#x003b3;t and IL-17A transcripts increased in murine hearts after MI. Additionally, immunohistochemical staining revealed that ROR&#x003b3;t-expressing cells infiltrated in the border zone after MI. Flow cytometric analysis showed that ROR&#x003b3;t-expressing cells were released from the spleen at day 1 after MI. Though ROR&#x003b3;t-expressing cells in spleen expressed &#x003b3;&#x003b4;TCR or CD4, &#x003b3;&#x003b4;TCR<sup>+</sup> cells were major population of ROR&#x003b3;t-expressing cells that infiltrated into post-infarct myocardium. To address the biological functions of ROR&#x003b3;t-expressing cells in infarcted hearts, we used mice with <italic>enhanced GFP</italic> gene heterozygously knocked-in at <italic>ROR&#x003b3;t</italic> locus (ROR&#x003b3;t<sup>+/-</sup> mice), which physiologically showed reduced expression of ROR&#x003b3;t mRNA in thymus. Kaplan-Meier analysis showed that MI-induced mortality was higher in ROR&#x003b3;t<sup>+/-</sup> mice than wild-type (WT) mice. Masson&#x02019;s trichrome staining demonstrated that cardiac injury was exacerbated in ROR&#x003b3;t<sup>+/-</sup> mice 7 days after MI (Injured area: ROR&#x003b3;t<sup>+/-</sup>; 42.1&#x000b1;6.5%, WT; 34.0&#x000b1;3.7%, circumference of injured myocardium: ROR&#x003b3;t<sup>+/-</sup>; 61.8&#x000b1;4.8%, WT; 49.6&#x000b1;5.1%), accompanied by exacerbation of cardiac function (fractional shortening: ROR&#x003b3;t<sup>+/-</sup>; 32.9&#x000b1;2.9%, WT; 38.3&#x000b1;3.6%). Moreover, immunohistochemical analyses revealed that capillary density in border zone was significantly reduced in ROR&#x003b3;t<sup>+/-</sup> mice after MI, compared with WT mice, associated with the reduced expression of angiopoietin 2. Finally, the mRNA expression of ROR&#x003b3;t, IL-17A, IL-17F and IL-23 receptor (IL-23R) mRNA and protein expression of IL-10 were decreased in ROR&#x003b3;t<sup>+/-</sup> hearts.</p></sec><sec id="sec003"><title>Conclusions</title><p>Heterozygous deletion of <italic>ROR&#x003b3;t</italic> gene resulted in aggravated cardiac remodeling, accompanied by reduced capillary density, after MI, suggesting that ROR&#x003b3;t-expressing cells contribute to tissue repair in infarcted myocardium.</p></sec></abstract><funding-group><award-group id="award001"><funding-source><institution>Ministry of Education, Culture, Sports, Science and Technology (MEXT)/ Japan Society for the Promotion of Science (JSPS) KAKENHI</institution></funding-source><award-id>23390057</award-id><principal-award-recipient><name><surname>Fujio</surname><given-names>Yasushi</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution>Ministry of Education, Culture, Sports, Science and Technology (MEXT)/ Japan Society for the Promotion of Science (JSPS) KAKENHI</institution></funding-source><award-id>26293054</award-id><principal-award-recipient><name><surname>Fujio</surname><given-names>Yasushi</given-names></name></principal-award-recipient></award-group><award-group id="award003"><funding-source><institution>Ministry of Education, Culture, Sports, Science and Technology (MEXT)/ Japan Society for the Promotion of Science (JSPS) KAKENHI</institution></funding-source><award-id>15K08232</award-id><principal-award-recipient><name><surname>Maeda</surname><given-names>Makiko</given-names></name></principal-award-recipient></award-group><award-group id="award004"><funding-source><institution>Ministry of Education, Culture, Sports, Science and Technology (MEXT)/ Japan Society for the Promotion of Science (JSPS) KAKENHI</institution></funding-source><award-id>15K18987</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3209-2208</contrib-id><name><surname>Obana</surname><given-names>Masanori</given-names></name></principal-award-recipient></award-group><funding-statement>This study was supported by Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI (<ext-link ext-link-type="uri" xlink:href="https://www.jsps.go.jp/english/e-grants/">https://www.jsps.go.jp/english/e-grants/</ext-link>); Grant numbers 23390057 and 26293054 to YF, 15K08232 to MM, and 15K18987 to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="6"/><table-count count="1"/><page-count count="15"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec004"><title>Introduction</title><p>Myocardial infarction (MI) is one of the major causes of heart failure. MI induces cardiomyocyte death, followed by infiltration of immune cells into post-infarct myocardium. The immune cells positively or negatively regulate myocardial inflammation and modulate adverse cardiac remodeling [<xref rid="pone.0183584.ref001" ref-type="bibr">1</xref>&#x02013;<xref rid="pone.0183584.ref003" ref-type="bibr">3</xref>]. For instance, neutrophils infiltrate into infarcted myocardium immediately after coronary occlusion and aggravate tissue damage by producing reactive oxygen species (ROS) [<xref rid="pone.0183584.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0183584.ref005" ref-type="bibr">5</xref>]. In contrast, macrophages contribute to the clearance of dead cells after MI and promote angiogenesis, leading to wound healing [<xref rid="pone.0183584.ref006" ref-type="bibr">6</xref>&#x02013;<xref rid="pone.0183584.ref008" ref-type="bibr">8</xref>]. Therefore, in order to understand the importance of immune cells in cardiac remodeling, it would be required to make clear the biological functions of immune cells based on cell-lineage in more detail.</p><p>The retinoic acid receptor-related orphan nuclear receptor &#x003b3;t (ROR&#x003b3;t) was originally identified as an essential transcription factor for IL-17A producing T cell differentiation [<xref rid="pone.0183584.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0183584.ref010" ref-type="bibr">10</xref>]. Physiologically, IL-17A plays important roles in host protection against the microbial infection in the bowels [<xref rid="pone.0183584.ref011" ref-type="bibr">11</xref>&#x02013;<xref rid="pone.0183584.ref013" ref-type="bibr">13</xref>]. IL-17A is also implicated in the pathogenesis of various inflammatory diseases such as atherosclerosis [<xref rid="pone.0183584.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0183584.ref015" ref-type="bibr">15</xref>], psoriasis [<xref rid="pone.0183584.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0183584.ref017" ref-type="bibr">17</xref>] and autoimmune diseases [<xref rid="pone.0183584.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0183584.ref019" ref-type="bibr">19</xref>]. Interestingly, recent studies have proposed that the deficiency of IL-17A could ameliorate left ventricular remodeling after MI [<xref rid="pone.0183584.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0183584.ref021" ref-type="bibr">21</xref>], suggesting that IL-17A is detrimental to the maintenance of cardiac homeostasis after MI; however, it is required to clarify the biological significance of ROR&#x003b3;t-expressing cells that produce IL-17A, because IL-17A is a pleiotropic cytokine and locally functions in various tissues.</p><p>ROR&#x003b3;t-expressing cells express various cytokines and cytokine receptors, including IL-17F and IL-23R, as well as IL-17A [<xref rid="pone.0183584.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0183584.ref023" ref-type="bibr">23</xref>]. In this study, we addressed the pathophysiological roles of ROR&#x003b3;t-expressing cells in cardiac remodeling after MI, using mice with <italic>enhanced GFP</italic> (<italic>eGFP</italic>) gene heterozygously knocked-in at <italic>ROR&#x003b3;t</italic> locus (ROR&#x003b3;t<sup>+/-</sup> mice), because homozygous deletion of ROR&#x003b3;t gene showed higher mortality by coronary ligation, compared with WT or ROR&#x003b3;t<sup>+/-</sup> mice, in our preliminary study. In ROR&#x003b3;t<sup>+/-</sup> mice, the myocardial expression of ROR&#x003b3;t and IL-17A was reduced in the heart after MI, compared with wild-type (WT) mice. Importantly, post-infarct cardiac remodeling was exacerbated in ROR&#x003b3;t<sup>+/-</sup> mice, accompanied by reduced capillary density, suggesting that ROR&#x003b3;t-expressing cells ameliorate cardiac remodeling after MI. The present study is the first demonstration that ROR&#x003b3;t-expressing cells exhibit cardioprotective properties after MI.</p></sec><sec sec-type="materials|methods" id="sec005"><title>Materials and methods</title><sec id="sec006"><title>Animal care</title><p>Animal care was performed according to the Osaka University animal care guidelines. The study was approved by the Institutional Animal Care and Use Committee of the Graduate School of Pharmaceutical Science, Osaka University (Permit Number; DOUYAKU 26&#x02013;4). All animal experiments were in accordance with the Guide for the Care and Use of Laboratory Animals, Eighth Edition, updated by the US National Research Council Committee in 2011. Male C57BL/6 mice (8&#x02013;12 weeks old, 25-30g body weight) were purchased from Japan SLC, Inc, and maintained on a 12 h light/dark cycle with free access to food and water at Animal Care Facility of Graduate School of Pharmaceutical Sciences, Osaka University. At the endpoints of all experiments, the hearts were excised from isoflurane-anesthetized mice. All efforts were made to minimize suffering.</p></sec><sec id="sec007"><title>Induction of MI</title><p>Murine MI was induced by permanent ligation of the left anterior descending coronary artery as previously described [<xref rid="pone.0183584.ref024" ref-type="bibr">24</xref>].</p></sec><sec id="sec008"><title>Splenectomy surgery</title><p>Mice were ventilated and anesthetized by isoflurane. After the left-side small laparotomy, splenic vessels were ligated with 7&#x02013;0 silk sutures and the spleen was removed. The peritoneum and skin were closed with 5&#x02013;0 silk sutures. MI operation was performed immediately after the splenic removal.</p></sec><sec id="sec009"><title>ROR&#x003b3;t-enhanced green fluorescence protein (eGFP) transgenic mice</title><p>The genetically engineered mice with <italic>eGFP</italic> cDNA knocked-in at <italic>ROR</italic>&#x003b3;<italic>t</italic> gene locus on a C57BL/6 background, designated as ROR&#x003b3;t<sup>+/-</sup> mice, were purchased from Jackson Laboratories (stock number: 007572). Genomic DNA was prepared from ROR&#x003b3;t WT, ROR&#x003b3;t<sup>+/-</sup>, and ROR&#x003b3;t<sup>-/-</sup> mice. The genotyping of ROR&#x003b3;t and eGFP was performed by PCR using specific primers. The primers used for genotyping were as follows: ROR&#x003b3;t and eGFP forward <monospace>5&#x02019;- GCC ACC TGT GTG GAG CAG AGC TTA -3&#x02019;</monospace>, ROR&#x003b3;t reverse <monospace>5&#x02019;- GGA TGC CCC CAT TCA CTT ACT TCT -3&#x02019;</monospace>, eGFP reverse <monospace>5&#x02019;- TCC TTG AAG AAG ATG GTG CG -3&#x02019;</monospace>. Because, in our preliminary study, ROR&#x003b3;t<sup>-/-</sup> mice showed higher mortality compared with WT or ROR&#x003b3;t<sup>+/-</sup> mice within 2 days after MI (WT: 7.1%, ROR&#x003b3;t<sup>+/-</sup>: 5.3%, ROR&#x003b3;t<sup>-/-</sup>: 25.0%). ROR&#x003b3;t<sup>+/-</sup> mice were used to evaluate the pathophysiological roles of ROR&#x003b3;t-expressing cells in cardiac remodeling.</p></sec><sec id="sec010"><title>Quantitative RT-PCR</title><p>Total RNA sample was prepared using QIAzol reagent (QIAGEN). RT-PCR was performed according to the manufacturer&#x02019;s protocol, as described previously [<xref rid="pone.0183584.ref025" ref-type="bibr">25</xref>]. The expression of ROR&#x003b3;t, VEGF, CXCL5, angiopoietin 2, IL-17A, IL-17F, IL-23R, IL-6, IL-1&#x003b2;, TNF-&#x003b1;, IFN-&#x003b3;, IL-10, and TGF-&#x003b2; mRNA in the left ventricle (LV) from the ligation point to the apex was estimated by real-time PCR using the SYBR green system (Applied Biosystems). The expression of GAPDH was measured and used as an internal control. The primers used in this study are shown in Supplementary material online, <xref ref-type="supplementary-material" rid="pone.0183584.s001">S1 Table</xref>.</p></sec><sec id="sec011"><title>Histological analysis</title><p>Cardiac injury was histologically estimated as described previously [<xref rid="pone.0183584.ref024" ref-type="bibr">24</xref>,<xref rid="pone.0183584.ref026" ref-type="bibr">26</xref>]. Briefly, hearts were harvested at day 7 after MI. The hearts were sliced from the position about 300 &#x003bc;m distal to the ligation point at 5-&#x003bc;m thickness, followed by staining with Masson&#x02019;s trichrome method. The area or circumference ratio of the injured region to LV was measured using Image J software (National Institutes of Health) by a researcher who was blinded to the experimental condition.</p><p>Immunohistochemical analysis was performed as described previously [<xref rid="pone.0183584.ref024" ref-type="bibr">24</xref>]. In brief, frozen sections were fixed with 4% paraformaldehyde (PFA) or acetone. ROR&#x003b3;t-expressing cells infiltration was stained using Histofine Mousestain kit (Nichirei Bioscience) with mouse anti-ROR&#x003b3;t monoclonal antibody (Clone: Q31-378, BD Bioscience). Mouse non-immune IgG (Santa Cruz Biotechnology) was used as control. Nuclei were counterstained with hematoxylin. To estimate the number of ROR&#x003b3;t-expressing cells, photomicrographs of border area and remote area were taken at random. Border area was defined as the region &#x0003c; 1 mm from the end of infarct area. ROR&#x003b3;t-positive cells were counted in number by the researcher who was blinded to the assay condition.</p><p>To estimate the capillary density, capillary vessels were stained using a Vectastain ABC kit (Vector Laboratories) with rat anti-CD31 monoclonal antibody (Clone: MEC13.3, BD Bioscience). Sections were photographed at border area, and then CD31-positive cells were counted in number by the researcher who was blinded to the assay condition.</p></sec><sec id="sec012"><title>Flow cytometric analysis</title><p>Spleens were harvested, triturated, and passed through a 70 &#x003bc;m cell strainer in PBS containing 3% fetal bovine serum (FBS). Cells were treated Lysing buffer (BD Bioscience) to exclude erythrocytes. To block Fc receptors, cells were incubated with rat anti-CD16/32 monoclonal antibody (Clone: 93, BioLegend) on ice for 15 minutes. Cells were stained surface markers with PE-conjugated armenian hamster anti-&#x003b3;&#x003b4;TCR monoclonal antibody (Clone: GL3, BioLegend) and FITC-conjugated rat anti-CD4 monoclonal antibody (Clone: RM4-5, BD Bioscience) on ice for 40 minutes. Transcription Factor Staining Buffer Set (eBioscience) was used for intracellular staining according to the manufacturer's protocol. After fixation and permeabilization, cells were stained with APC-conjugated rat anti-ROR&#x003b3;t antibody (Clone: B2D, eBioscience) on ice for 40 minutes. Isotype-control staining was performed using FITC- or APC-conjugated rat control IgG (Clone: RTK2758, BioLeged) and PE-conjugated rat control IgG (Clone: R35-95, BD Bioscience). Flow cytometric analysis was performed on FACS Aria II (BD Bioscience) and analyzed using BD FACS Diva software (BD Bioscience).</p></sec><sec id="sec013"><title>Analysis of cardiac function by echocardiography</title><p>Echocardiography was performed as described previously [<xref rid="pone.0183584.ref025" ref-type="bibr">25</xref>].</p></sec><sec id="sec014"><title>Gravimetric analysis</title><p>Mice were weighted at day 7 after MI. The heart and lung were harvested after euthanasia by inhalation of isoflurane and washed with cold PBS. The weight of these organs was measured and normalized with body weight.</p></sec><sec id="sec015"><title>Enzyme-linked immunosorbent assay</title><p>Heart homogenates were prepared and IL-10 concentration in myocardium was evaluated with ELISA kit (BioLegend, ELISA MAX<sup>TM</sup> Deluxe Set#431414).</p></sec><sec id="sec016"><title>Statistical analysis</title><p>Data are shown as means &#x000b1; SD. Survival rate was analyzed by the Kaplan-Meier method using a log-rank test. Comparisons between two groups were performed with the use of Student <italic>t</italic>-test. One-way ANOVA followed by a Tukey-Kramer or Dunnett test was used for multiple comparisons. <italic>P</italic> value &#x0003c; 0.05 was considered to be statistically significant.</p></sec></sec><sec sec-type="results" id="sec017"><title>Results</title><sec id="sec018"><title>ROR&#x003b3;t-expressing cells infiltrated in the heart after MI</title><p>We examined the expression of ROR&#x003b3;t and IL-17A mRNA in post-infarct myocardium by quantitative RT-PCR (<xref ref-type="fig" rid="pone.0183584.g001">Fig 1A</xref>). After C57BL/6 mice were subjected to MI, mRNA expression was measured at various time points. The expression of ROR&#x003b3;t and IL-17A transcripts was upregulated at day 1 and the expression of these genes displayed its peak at day 7 after MI. Consistently, immunohistochemical staining with anti-ROR&#x003b3;t antibody revealed that ROR&#x003b3;t-expressing cells infiltrated in the border area after MI, but not in remote area or sham operated hearts (<xref ref-type="fig" rid="pone.0183584.g001">Fig 1B and 1C</xref>). Previously, we demonstrated that ROR&#x003b3;t-expressing cells are required for the onset of experimental autoimmune myocarditis (EAM) [<xref rid="pone.0183584.ref027" ref-type="bibr">27</xref>]. Interestingly, it is reported that EAM is produced by adoptive transfer of splenocytes after MI [<xref rid="pone.0183584.ref028" ref-type="bibr">28</xref>]. Therefore, we examined the effects of the splenectomy on the infiltration of ROR&#x003b3;t-expressing cells into post-infarct myocardium and found that the number of ROR&#x003b3;t-expressing cells infiltration was reduced by splenectomy surgery (<xref ref-type="fig" rid="pone.0183584.g001">Fig 1B and 1C</xref>). These data indicate that ROR&#x003b3;t-expressing cells were released at least partially from the spleen. It should be noted that the infiltration of ROR&#x003b3;t-expressing cells was not completely inhibited by splenectomy, suggesting that some fraction of ROR&#x003b3;t-expressing cells were originated from other lymphoid tissues, such as lymph nodes.</p><fig id="pone.0183584.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0183584.g001</object-id><label>Fig 1</label><caption><title>ROR&#x003b3;t-expressing cells infiltrated in the heart after MI.</title><p>(A) C57BL/6 mice were subjected to MI operation, and hearts were harvested at the indicated time points. Total RNA was prepared from the ligation point to the apex of hearts, and quantitative RT-PCR was performed for ROR&#x003b3;t (left) and IL-17A (right). The expression of ROR&#x003b3;t and IL-17A mRNA was normalized with that of GAPDH and were shown as a ratio to the average value of non-MI. Data are shown as means &#x000b1; SD; n = 7 for each condition. *<italic>P</italic> &#x0003c; 0.05 and **<italic>P</italic> &#x0003c; 0.01 vs non-MI by one-way ANOVA followed by Dunnett test. (B) The sections were prepared from the hearts at day 7 after MI, MI plus splenectomy or sham operation. Immunohistochemical analyses were performed with anti-ROR&#x003b3;t antibody or mouse non-immune IgG as a control. Nuclei were stained by hematoxylin (Blue). Representative images at border zone and remote area are shown. The arrowhead indicates ROR&#x003b3;t-positive cell (Brown). Bar = 50 &#x003bc;m. (C) Quantitative analyses of ROR&#x003b3;t-expressing cells. Thirty visual fields at the border zone or remote area were photographed from 5 hearts. Cells that were positively stained with anti-ROR&#x003b3;t at nuclei were counted. Data are shown as means &#x003b3; SD. n.d., not detectable, **<italic>P</italic> &#x0003c; 0.01 by one-way ANOVA followed by Turkey-Kramer test.</p></caption><graphic xlink:href="pone.0183584.g001"/></fig></sec><sec id="sec019"><title>ROR&#x003b3;t-expressing cells were released from the spleen after MI</title><p>Since splenectomy reduced the number of ROR&#x003b3;t-expressing cells that infiltrated post-infarct myocardium, we performed flow cytometric analysis for splenic leukocytes to characterize ROR&#x003b3;t-expressing cells. Consistent with ROR&#x003b3;t-expressing cells infiltration in infarcted heart, the number of leukocytes and ROR&#x003b3;t-expressing cells in the spleen was reduced at day 1 after MI (<xref ref-type="fig" rid="pone.0183584.g002">Fig 2A</xref>). The staining of cell surface markers revealed that ROR&#x003b3;t-expressing cells consist of ROR&#x003b3;t<sup>+</sup> &#x003b3;&#x003b4;TCR<sup>+</sup> cells and ROR&#x003b3;t<sup>+</sup> CD4<sup>+</sup> cells (<xref ref-type="fig" rid="pone.0183584.g002">Fig 2B</xref>). We analyzed temporal changes of both ROR&#x003b3;t<sup>+</sup> &#x003b3;&#x003b4;TCR<sup>+</sup> cells and ROR&#x003b3;t<sup>+</sup> CD4<sup>+</sup> cells in the spleen after MI. ROR&#x003b3;t<sup>+</sup> &#x003b3;&#x003b4;TCR<sup>+</sup> cells were more abundantly released from the spleen from day 1 to day 7 after MI, while ROR&#x003b3;t<sup>+</sup> CD4<sup>+</sup> cells were transiently released at day1 (<xref ref-type="fig" rid="pone.0183584.g002">Fig 2C</xref>). Considering that the expression of ROR&#x003b3;t increased in the heart from day 1 to day 7 after MI, it is likely that majority of ROR&#x003b3;t-expressing cells in post-infarct myocardium are ROR&#x003b3;t<sup>+</sup> &#x003b3;&#x003b4;TCR<sup>+</sup> cells.</p><fig id="pone.0183584.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0183584.g002</object-id><label>Fig 2</label><caption><title>ROR&#x003b3;t-expressing cells were released from spleen after MI.</title><p>(A) Quantitative analyses of the number of splenic leukocytes (left) and ROR&#x003b3;t-expressing cells (right). Data are shown as means &#x000b1; SD; n = 5 for non-MI, 6 for each MI conditions. *<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01 by one-way ANOVA followed by Dunnett test. (B) &#x003b3;&#x003b4;TCR<sup>+</sup> ROR&#x003b3;t<sup>+</sup> cells (upper) and CD4<sup>+</sup> ROR&#x003b3;t<sup>+</sup> cells (bottom) were detected by flow cytometric analysis. Blots are representative of 4 independents experimental conditions. (C) Quantitative analyses of the number of &#x003b3;&#x003b4;TCR<sup>+</sup> ROR&#x003b3;t<sup>+</sup> cells (left) and CD4<sup>+</sup> ROR&#x003b3;t<sup>+</sup> cells (right). Data are shown as means &#x000b1; SD; n = 5 for non-MI, 6 for each MI groups. *<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01 vs non-MI by one-way ANOVA followed by Dunnett test.</p></caption><graphic xlink:href="pone.0183584.g002"/></fig></sec><sec id="sec020"><title>Heterozygous deletion of ROR&#x003b3;t gene increased the mortality after MI</title><p>To analyze the pathophysiological significance of ROR&#x003b3;t-expressing cells in post-infarct myocardium, we used ROR&#x003b3;t<sup>+/-</sup> mice with <italic>eGFP</italic> gene heterozygously knocked-in at <italic>ROR&#x003b3;t</italic> gene locus (<xref ref-type="fig" rid="pone.0183584.g003">Fig 3A</xref>). In order to confirm that <italic>ROR&#x003b3;t</italic> gene was successfully reduced in ROR&#x003b3;t<sup>+/-</sup> mice, we examined physiological expression of ROR&#x003b3;t mRNA in the thymus by quantitative RT-PCR analysis, because ROR&#x003b3;t mRNA is constitutively expressed in the thymus [<xref rid="pone.0183584.ref009" ref-type="bibr">9</xref>]. The ROR&#x003b3;t mRNA expression was significantly suppressed in the thymus in ROR&#x003b3;t<sup>+/-</sup> mice compared with WT mice (<xref ref-type="fig" rid="pone.0183584.g003">Fig 3B</xref>). Similarly, the expression of ROR&#x003b3;t in spleen has tendency to decrease in ROR&#x003b3;t<sup>+/-</sup> mice with wide standard deviation, possibly because splenic cells are composed of more various immune cells than thymic cells. In comparison with the thymus, the expression of ROR&#x003b3;t mRNA in non-MI hearts was very low in both ROR&#x003b3;t<sup>+/-</sup> and WT mice. Consistently, echocardiographic analysis showed that there was no difference in cardiac function between these two groups of mice before MI (<xref ref-type="table" rid="pone.0183584.t001">Table 1</xref>). However, after MI, ROR&#x003b3;t<sup>+/-</sup> mice showed higher rate of mortality (<xref ref-type="fig" rid="pone.0183584.g003">Fig 3C</xref>), accompanied by aggravated cardiac dysfunction at day 7 after MI, compared with WT mice (<xref ref-type="table" rid="pone.0183584.t001">Table 1</xref>).</p><fig id="pone.0183584.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0183584.g003</object-id><label>Fig 3</label><caption><title>Heterozygous deletion of ROR&#x003b3;t gene increased the mortality after MI.</title><p>(A) The representative image of PCR products of ROR&#x003b3;t and eGFP from genomic DNA. (B) Total RNA was prepared from thymus, spleen and heart of ROR&#x003b3;t<sup>+/-</sup> or WT mice. Quantitative RT-PCR was performed for ROR&#x003b3;t. The expression of ROR&#x003b3;t mRNA was normalized with that of GAPDH. The expression levels were calculated as a ratio to the average value of thymus on WT mice. Data are shown as means &#x000b1; SD; n = 3 for thymus of WT and ROR&#x003b3;t<sup>+/-</sup> mice, heart of WT and ROR&#x003b3;t<sup>+/-</sup> mice, spleen of ROR&#x003b3;t<sup>+/-</sup> mice, n = 6 for spleen of WT mice. **<italic>P</italic> &#x0003c; 0.01 vs WT mice by Student&#x02019;s <italic>t</italic>-test. (C) Kaplan-Meier analyses of survival rate after MI or sham operation. Mice were subjected to MI or sham operation. n = 18 for WT mice with MI, 20 for ROR&#x003b3;t<sup>+/-</sup> mice with MI, 6 for each group with sham operation. The survival rate after MI or sham operation was estimated by the Kaplan-Meier method. *<italic>P</italic> &#x0003c; 0.05 vs WT mice by log-rank test.</p></caption><graphic xlink:href="pone.0183584.g003"/></fig><table-wrap id="pone.0183584.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0183584.t001</object-id><label>Table 1</label><caption><title>Echocardiographic analyses on the cardiac function.</title></caption><alternatives><graphic id="pone.0183584.t001g" xlink:href="pone.0183584.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Days after MI</th><th align="center" colspan="2" rowspan="1">0</th><th align="center" colspan="2" rowspan="1">2</th><th align="center" colspan="2" rowspan="1">7</th></tr><tr><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">WT</th><th align="center" rowspan="1" colspan="1">ROR&#x003b3;t<sup>+/-</sup></th><th align="center" rowspan="1" colspan="1">WT</th><th align="center" rowspan="1" colspan="1">ROR&#x003b3;t<sup>+/-</sup></th><th align="center" rowspan="1" colspan="1">WT</th><th align="center" rowspan="1" colspan="1">ROR&#x003b3;t<sup>+/-</sup></th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">FS (%)</td><td align="center" rowspan="1" colspan="1">51.6&#x000b1;3.2</td><td align="center" rowspan="1" colspan="1">52.0&#x000b1;2.7</td><td align="center" rowspan="1" colspan="1">46.5&#x000b1;3.1<xref ref-type="table-fn" rid="t001fn003"><sup>&#x000a7;</sup></xref></td><td align="center" rowspan="1" colspan="1">44.8&#x000b1;1.6<xref ref-type="table-fn" rid="t001fn004"><sup>&#x02021;</sup></xref></td><td align="center" rowspan="1" colspan="1">38.3&#x000b1;3.6<xref ref-type="table-fn" rid="t001fn003"><sup>&#x000a7;</sup></xref></td><td align="center" rowspan="1" colspan="1">32.9&#x000b1;2.9<xref ref-type="table-fn" rid="t001fn004"><sup>&#x02021;</sup></xref><xref ref-type="table-fn" rid="t001fn002">*</xref></td></tr><tr><td align="center" rowspan="1" colspan="1">HR (bpm)</td><td align="center" rowspan="1" colspan="1">520.4&#x000b1;56.1</td><td align="center" rowspan="1" colspan="1">539.4&#x000b1;46.2</td><td align="center" rowspan="1" colspan="1">486.2&#x000b1;96.2</td><td align="center" rowspan="1" colspan="1">471.7&#x000b1;50.1</td><td align="center" rowspan="1" colspan="1">529.8&#x000b1;57.9</td><td align="center" rowspan="1" colspan="1">487.8&#x000b1;55.8</td></tr><tr><td align="center" rowspan="1" colspan="1">LVIDd (mm)</td><td align="center" rowspan="1" colspan="1">3.7&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">3.4&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">4.2&#x000b1;0.4</td><td align="center" rowspan="1" colspan="1">4.0&#x000b1;0.4</td><td align="center" rowspan="1" colspan="1">4.9&#x000b1;0.7<xref ref-type="table-fn" rid="t001fn003"><sup>&#x000a7;</sup></xref></td><td align="center" rowspan="1" colspan="1">4.9&#x000b1;0.5<xref ref-type="table-fn" rid="t001fn004"><sup>&#x02021;</sup></xref></td></tr><tr><td align="center" rowspan="1" colspan="1">LVIDs (mm)</td><td align="center" rowspan="1" colspan="1">1.8&#x000b1;0.2</td><td align="center" rowspan="1" colspan="1">1.8&#x000b1;0.2</td><td align="center" rowspan="1" colspan="1">2.2&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">2.2&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">3.0&#x000b1;0.5<xref ref-type="table-fn" rid="t001fn003"><sup>&#x000a7;</sup></xref></td><td align="center" rowspan="1" colspan="1">3.3&#x000b1;0.4<xref ref-type="table-fn" rid="t001fn004"><sup>&#x02021;</sup></xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>FS; Fractional Shortening, HR; Heart Rate, LVIDd; Left Ventricular Internal Dimension in diastole, LVIDs; Left Ventricular Internal Dimension in systole. Data are shown as mean &#x000b1; S.D; n = 14 for day 0-WT mice, 11 for day 0-ROR&#x003b3;t<sup>+/-</sup> mice, 17 for day 2-WT mice, 11 for day 2-ROR&#x003b3;t<sup>+/-</sup> mice, 17 for day 7-WT mice, 13 for day 7-ROR&#x003b3;t<sup>+/-</sup> mice.</p></fn><fn id="t001fn002"><p>*<italic>P</italic>&#x0003c;0.01 vs day 7-WT mice</p></fn><fn id="t001fn003"><p><sup><bold>&#x000a7;</bold></sup><italic>P</italic>&#x0003c;0.01 vs day 0-WT mice</p></fn><fn id="t001fn004"><p><sup><bold>&#x02021;</bold></sup><italic>P</italic>&#x0003c;0.01 vs day 0-ROR&#x003b3;t<sup>+/-</sup> mice by one-way ANOVA followed by Tukey-Kramer test.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec021"><title>Adverse cardiac remodeling was exacerbated in ROR&#x003b3;t<sup>+/-</sup> mice after MI</title><p>To make clear the effects of ROR&#x003b3;t knockdown on adverse cardiac remodeling after MI, we conducted gravimetric analysis and measured severity of cardiac injury in ROR&#x003b3;t<sup>+/-</sup> and WT mice (<xref ref-type="fig" rid="pone.0183584.g004">Fig 4</xref>). In this study, we analyzed cardiac remodeling at day 7 after MI, because approximately 80% of ROR&#x003b3;t<sup>+/-</sup> mice died by day 14 (<xref ref-type="fig" rid="pone.0183584.g003">Fig 3C</xref>). Consistent with the aggravated cardiac dysfunction in ROR&#x003b3;t<sup>+/-</sup> mice at day 7 after MI, the ratio of heart weight to body weight and lung weight to body weight were both increased in ROR&#x003b3;t<sup>+/-</sup> mice after MI, compared with WT mice (<xref ref-type="fig" rid="pone.0183584.g004">Fig 4A</xref>). Histological analyses by Masson&#x02019;s trichrome staining revealed that severity of cardiac injury, including cardiac fibrosis, was exacerbated in ROR&#x003b3;t<sup>+/-</sup> mice after MI, although there was no histological difference between ROR&#x003b3;t<sup>+/-</sup> mice and WT mice in sham-operated groups (<xref ref-type="fig" rid="pone.0183584.g004">Fig 4B</xref>). We quantified injured area and circumference, and found that cardiac injury was significantly increased in ROR&#x003b3;t<sup>+/-</sup> mice (<xref ref-type="fig" rid="pone.0183584.g004">Fig 4B and 4C</xref>).</p><fig id="pone.0183584.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0183584.g004</object-id><label>Fig 4</label><caption><title>Adverse cardiac remodeling was exacerbated in ROR&#x003b3;t<sup>+/-</sup> mice after MI.</title><p>(A) The heart weight-to-body weight ratio (HW/BW, left) and the lung weight-to-body weight ratio (LW/BW, right) were estimated. Data are shown as means &#x000b1; SD; n = 8 for WT mice with non-MI, 7 for ROR&#x003b3;t<sup>+/-</sup> mice with non-MI, 8 for WT mice with MI, 18 for ROR&#x003b3;t<sup>+/-</sup> mice with MI. *<italic>P</italic> &#x0003c; 0.05 and **<italic>P</italic> &#x0003c; 0.01 by Turkey-Kramer test. Heart sections were prepared at day 7 after MI and stained with Masson&#x02019;s trichrome method. (B) Representative images. Bar = 1 mm. (C) Upper, the image and method for analyzing the cardiac injury. Lower-left, the ratio of injured area to left ventricular (LV) area of MI operated mice. Lower-right, the ratio of injured circumference to LV circumference of MI operated mice. Data are shown as means &#x000b1; SD; n = 15 for WT mice, 11 for ROR&#x003b3;t<sup>+/-</sup> mice. **<italic>P</italic> &#x0003c; 0.01 vs WT mice by Student&#x02019;s <italic>t</italic>-test.</p></caption><graphic xlink:href="pone.0183584.g004"/></fig></sec><sec id="sec022"><title>Capillary density was reduced in ROR&#x003b3;t<sup>+/-</sup> hearts after MI</title><p>Impaired vascular formation in post-infarct myocardium aggravates adverse cardiac remodeling [<xref rid="pone.0183584.ref029" ref-type="bibr">29</xref>,<xref rid="pone.0183584.ref030" ref-type="bibr">30</xref>]. Therefore, we measured capillary density at day 7 after MI by immunohistochemical staining with anti-CD31 antibody (<xref ref-type="fig" rid="pone.0183584.g005">Fig 5</xref>). In the border zone, capillary density was significantly reduced in ROR&#x003b3;t<sup>+/-</sup> mice relative to WT mice, whereas there was no difference between WT and ROR&#x003b3;t<sup>+/-</sup> mice in sham-operation. To explore the mechanisms of impaired angiogenesis in ROR&#x003b3;t<sup>+/-</sup> mice, the mRNA expression of angiogenetic factors, such as VEGF, CXCL5 and angiopoietin 2, was measured by quantitative PCR. While VEGF and CXCL5 mRNA expressions were unchanged between ROR&#x003b3;t<sup>+/-</sup> mice and WT mice, angiopoietin 2 expression was significantly reduced in ROR&#x003b3;t<sup>+/-</sup> mice at day 4 after MI (<xref ref-type="fig" rid="pone.0183584.g005">Fig 5C</xref>).</p><fig id="pone.0183584.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0183584.g005</object-id><label>Fig 5</label><caption><title>Capillary density was reduced in ROR&#x003b3;t<sup>+/-</sup> hearts after MI.</title><p>(A) Capillaries in the heart were detected by immunohistochemical staining with anti-CD31 antibody. Representative images at border zone are shown. Bar = 50 &#x000b5;m. (B) Sixty visual fields at the border zone from 5 hearts were randomly selected. The number of CD31-positive cells was counted to calculate the capillary density. Data are shown as means &#x000b1; SD. **<italic>P</italic> &#x0003c; 0.01 by one-way ANOVA followed by Turkey-Kramer test. (C) Quantitative RT-PCR was performed for VEGF, CXCL5 and angiopoietin 2 at day 4 after MI. The expression of the transcripts was normalized with that of GAPDH and shown as the ratio to the average value of WT mice. Data are shown as means &#x000b1; SD; n = 4. **<italic>P</italic> &#x0003c; 0.01 vs WT mice by Student&#x02019;s <italic>t</italic>-test.</p></caption><graphic xlink:href="pone.0183584.g005"/></fig></sec><sec id="sec023"><title>Effects of heterozygous ROR&#x003b3;t deletion on cytokine production in post-infarct myocardium</title><p>The inflammatory reaction is closely associated with the progression of cardiac remodeling. Therefore, to assess the effects of heterozygous ROR&#x003b3;t deletion on cytokine production, we performed quantitative RT-PCR and estimated mRNA expression of cytokines and their related genes (<xref ref-type="fig" rid="pone.0183584.g006">Fig 6</xref>). The myocardial expression of ROR&#x003b3;t, IL-17A, IL-17F, and IL-23R mRNA was significantly suppressed in ROR&#x003b3;t<sup>+/-</sup> mice at day 7 after MI, compared with WT mice, respectively. Consistent with previous reports that IL-17 was thought to be only increased locally in the infarcted region after MI [<xref rid="pone.0183584.ref031" ref-type="bibr">31</xref>,<xref rid="pone.0183584.ref032" ref-type="bibr">32</xref>], there was no significant difference in serum IL-17 level between ROR&#x003b3;t<sup>+/-</sup> and WT mice after MI (<xref ref-type="supplementary-material" rid="pone.0183584.s002">S1 Fig</xref>). Moreover, the expression of pro-inflammatory cytokines, including IL-6, IL-1&#x003b2;, TNF-&#x003b1;, and IFN-&#x003b3;, as well as anti-inflammatory cytokines, including IL-10 and TGF-&#x003b2;, was not influenced by heterozygous deletion of <italic>ROR&#x003b3;t</italic> gene. Whereas, ELISA revealed that IL-10 protein in myocardium was reduced in ROR&#x003b3;t<sup>+/-</sup> mice in comparison to control mice at day7 after MI.</p><fig id="pone.0183584.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0183584.g006</object-id><label>Fig 6</label><caption><title>Effects of heterozygous ROR&#x003b3;t deletion on cytokine production in post-infarct myocardium.</title><p>(A) ROR&#x003b3;t<sup>+/-</sup> mice and WT mice were subjected to MI operation, and hearts were harvested at day 7 after MI. Total RNA was prepared from hearts from the ligation point to the apex, and quantitative RT-PCR was performed for ROR&#x003b3;t, IL-17A, IL-17F, IL-23R IL-6, IL-1&#x003b2;, TNF-&#x003b1;, IFN-&#x003b3;, IL-10 and TGF-&#x003b2; mRNA levels. The expressions of the transcripts were normalized with that of GAPDH and shown as the ratio to the average value of WT mice. Data are shown as means &#x000b1; SD; n = 13 for WT mice, 8 for ROR&#x003b3;t<sup><bold>+/-</bold></sup> mice. *<italic>P</italic> &#x0003c; 0.05 and **<italic>P</italic> &#x0003c; 0.01 vs WT mice by Student&#x02019;s <italic>t</italic>-test. (B) Heart homogenate was prepared from infarct hearts of ROR&#x003b3;t<sup>+/-</sup> mice and WT mice at day 7 after MI. ELISA was performed to evaluate the concentration of IL-10 protein. Data are shown as means &#x000b1; SD; n = 6 for WT mice, n = 7 for ROR&#x003b3;t+/- mice. **<italic>P</italic> &#x0003c; 0.01 vs WT mice by Student&#x02019;s <italic>t</italic>-test.</p></caption><graphic xlink:href="pone.0183584.g006"/></fig></sec></sec><sec sec-type="conclusions" id="sec024"><title>Discussion</title><p>In post-infarct myocardium, immune cells positively or negatively modulate cardiac remodeling [<xref rid="pone.0183584.ref001" ref-type="bibr">1</xref>&#x02013;<xref rid="pone.0183584.ref008" ref-type="bibr">8</xref>]. Here, we have demonstrated that ROR&#x003b3;t-expressing cells infiltrated into myocardium after MI. To analyze the pathophysiological roles of ROR&#x003b3;t-expressing cells, MI was generated in ROR&#x003b3;t<sup>+/-</sup> mice with <italic>eGFP</italic> gene heterozygously knocked-in at ROR&#x003b3;t locus. In ROR&#x003b3;t<sup>+/-</sup> mice, the mortality was increased with reduced expression of ROR&#x003b3;t and IL-17A transcripts in post-infarct myocardium. Importantly, adverse cardiac remodeling was exacerbated in ROR&#x003b3;t<sup>+/-</sup> mice, accompanied by reduced capillary density. These data suggest that ROR&#x003b3;t-expressing cells play cardioprotective roles in cardiac remodeling after MI.</p><p>In this study, we used ROR&#x003b3;t<sup>+/-</sup> mice instead of ROR&#x003b3;t-deficient mice, because ROR&#x003b3;t<sup>-/-</sup> mice showed higher mortality immediately after MI. ROR&#x003b3;t<sup>+/-</sup> mice grew normally and echocardiography showed that there was no difference in cardiac function between ROR&#x003b3;t<sup>+/-</sup> and WT mice under physiological conditions. We confirmed that the expression level of ROR&#x003b3;t transcript in the thymus was reduced by 41% in ROR&#x003b3;t<sup>+/-</sup> mice, compared with WT, indicating that ROR&#x003b3;t<sup>+/-</sup> mice could be used as ROR&#x003b3;t knock-down model.</p><p>ROR&#x003b3;t was originally identified as a transcription factor responsible for differentiation of IL-17-producing T cells [<xref rid="pone.0183584.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0183584.ref010" ref-type="bibr">10</xref>]. Previously, we have demonstrated that ROR&#x003b3;t is essential for the induction of experimental autoimmune myocarditis (EAM) [<xref rid="pone.0183584.ref027" ref-type="bibr">27</xref>]; however, the pathophysiological roles of ROR&#x003b3;t-expressing cells poorly understand in cardiac remodeling after MI. ROR&#x003b3;t is a transcriptional factor for various cytokines and their receptors, including IL-17A, IL-17F and IL-23R [<xref rid="pone.0183584.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0183584.ref023" ref-type="bibr">23</xref>]. Indeed, the expression of these cytokines and cytokine receptors was reduced in post-infarct myocardium in ROR&#x003b3;t<sup>+/-</sup> mice. Interestingly, we showed that heterozygous deletion of <italic>ROR&#x003b3;t</italic> gene exacerbated adverse cardiac remodeling after MI, suggesting that ROR&#x003b3;t-expressing cells could prevent cardiac remodeling.</p><p>Though ROR&#x003b3;t is essential for Th17 differentiation, ROR&#x003b3;t expression is not limited to Th17 cells [<xref rid="pone.0183584.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0183584.ref023" ref-type="bibr">23</xref>]. Our data presented here propose that ROR&#x003b3;t-mediated regulation of inflammatory reaction could be crucial for protection from adverse cardiac remodeling, independently of Th17 cells. Importantly, we demonstrated that ROR&#x003b3;t-expressing cells, released from the spleen at day1 to 7 after MI, were &#x003b3;&#x003b4;T cells. Recently, two types of &#x003b3;&#x003b4;T cells have been identified [<xref rid="pone.0183584.ref033" ref-type="bibr">33</xref>]; one is ROR&#x003b3;t<sup>+</sup> IL-17<sup>+</sup> &#x003b3;&#x003b4;T cell and the other is ROR&#x003b3;t<sup>-</sup> IFN-&#x003b3;<sup>+</sup> &#x003b3;&#x003b4;T cell. Consistent with our results, IL-17-producing &#x003b3;&#x003b4;T cells are known to contribute to tissue repair by promoting angiogenesis [<xref rid="pone.0183584.ref034" ref-type="bibr">34</xref>,<xref rid="pone.0183584.ref035" ref-type="bibr">35</xref>].</p><p>Recently, it was reported that &#x003b3;&#x003b4;TCR-KO mice exhibited improved survival and cardiac function after MI [<xref rid="pone.0183584.ref020" ref-type="bibr">20</xref>], while we have demonstrated that ROR&#x003b3;t-expressing &#x003b3;&#x003b4;TCR<sup>+</sup> cells play protective roles. The inconsistency between these two studies might be explained by the heterogeneity of &#x003b3;&#x003b4;TCR<sup>+</sup> cells. As described above, &#x003b3;&#x003b4;TCR<sup>+</sup> cells consist of at least 2 populations, INF-&#x003b3; producing &#x003b3;&#x003b4;TCR<sup>+</sup> cells and IL-17 producing &#x003b3;&#x003b4;TCR<sup>+</sup> cells. The expression of IL-17 was reduced in ROR&#x003b3;t<sup>+/-</sup> myocardium after MI, while that of INF-&#x003b3; was not. Therefore, ROR&#x003b3;t-expressing &#x003b3;&#x003b4;TCR<sup>+</sup> cells, observed in this study, are mainly IL-17 producing &#x003b3;&#x003b4;TCR<sup>+</sup> cells. In other words, the inconsistent results of these two studies might imply that additional subpopulation of &#x003b3;&#x003b4;TCR<sup>+</sup> cells could exert detrimental effects on cardiac remodeling after MI, though further studies would be needed to identify the subpopulation.</p><p>It is interesting that capillary density was reduced in myocardium of ROR&#x003b3;t<sup>+/-</sup> mice after MI. Since angiogenesis prevents post-infarct cardiac fibrosis [<xref rid="pone.0183584.ref029" ref-type="bibr">29</xref>,<xref rid="pone.0183584.ref030" ref-type="bibr">30</xref>], it is proposed that ROR&#x003b3;t-expressing cells ameliorated cardiac remodeling at least partially by promoting angiogenesis. This proposal is supported by the finding that the expression of IL-17A and angiopoietin 2 was reduced in post-infarct myocardium in ROR&#x003b3;t<sup>+/-</sup> mice. It is well known that IL-17A promotes vascular formation [<xref rid="pone.0183584.ref036" ref-type="bibr">36</xref>,<xref rid="pone.0183584.ref037" ref-type="bibr">37</xref>]. Moreover, angiopoietin 2 positively regulates angiogenesis in autoimmune diseases [<xref rid="pone.0183584.ref038" ref-type="bibr">38</xref>]. Of course, we cannot exclude the possibility that other secretory factors or cytokines, produced from ROR&#x003b3;t-expressing cells, were involved in cardioprotection, because it was reported that deficiency of IL-17A prevented cardiac remodeling and that IL-17A does not necessarily show the beneficial effects on cardiac remodeling [<xref rid="pone.0183584.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0183584.ref021" ref-type="bibr">21</xref>].</p><p>In the present study, we have demonstrated that heterozygous ablation of <italic>ROR&#x003b3;t</italic> gene exacerbated cardiac remodeling after MI. ROR&#x003b3;t-expressing &#x003b3;&#x003b4;T cells exhibited preventive effects against cardiac remodeling at least partially through enhanced revascularization, proposing the cardioprotective property as a novel function of ROR&#x003b3;t-expressing &#x003b3;&#x003b4;T cells. Modulation of ROR&#x003b3;t<sup>+</sup> cell-mediated regulation of cardiac remodeling could be a promising therapeutic strategy for cardiovascular diseases.</p><p>Limitations: It should be noted that male mice were exclusively used in this study as a limitation. In our previous study [<xref rid="pone.0183584.ref027" ref-type="bibr">27</xref>], we examined the pathophysiological roles of ROR&#x003b3;t in experimental autoimmune myocarditis (EAM) and found that ROR&#x003b3;t is essential for the onset of EAM. In EAM experiments, we exclusively used male Balb/c mice because EAM can be induced more severely in male mice than in female, as reported previously [<xref rid="pone.0183584.ref039" ref-type="bibr">39</xref>]. Therefore, considering the possibility that the biological function of ROR&#x003b3;t is dependent on sex difference and can be more remarkably observed in male mice, we designed this study as an exclusive study of male mice to make clear the biological roles of ROR&#x003b3;t in cardiac remodeling after MI.</p></sec><sec sec-type="supplementary-material" id="sec025"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0183584.s001"><label>S1 Table</label><caption><title>Primers used in this study.</title><p>(DOCX)</p></caption><media xlink:href="pone.0183584.s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0183584.s002"><label>S1 Fig</label><caption><title>Serum IL-17 concentration was similar level between ROR&#x003b3;t+/- mice and WT mice.</title><p>(TIF)</p></caption><media xlink:href="pone.0183584.s002.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Chiharu Tottori for her excellent administrative work.</p></ack><ref-list><title>References</title><ref id="pone.0183584.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Nian</surname><given-names>M</given-names></name>, <name><surname>Lee</surname><given-names>P</given-names></name>, <name><surname>Khaper</surname><given-names>N</given-names></name>, <name><surname>Liu</surname><given-names>P</given-names></name>. <article-title>Inflammatory cytokines and postmyocardial infarction remodeling</article-title>. <source>Circ Res</source>. <year>2004</year>; <volume>94</volume>: <fpage>1543</fpage>&#x02013;<lpage>1553</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.RES.0000130526.20854.fa">10.1161/01.RES.0000130526.20854.fa</ext-link></comment>
<pub-id pub-id-type="pmid">15217919</pub-id></mixed-citation></ref><ref id="pone.0183584.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Frangogiannis</surname><given-names>NG</given-names></name>. <article-title>Chemokines in the ischemic myocardium: from inflammation to fibrosis</article-title>. <source>Inflamm Res</source>. <year>2004</year>; <volume>53</volume>: <fpage>585</fpage>&#x02013;<lpage>595</lpage>. <pub-id pub-id-type="pmid">15693606</pub-id></mixed-citation></ref><ref id="pone.0183584.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Frantz</surname><given-names>S</given-names></name>, <name><surname>Bauersachs</surname><given-names>J</given-names></name>, <name><surname>Ertl</surname><given-names>G</given-names></name>. <article-title>Post-infarct remodelling: contribution of wound healing and inflammation</article-title>. <source>Cardiovasc Res</source>. <year>2009</year>; <volume>81</volume>: <fpage>474</fpage>&#x02013;<lpage>481</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/cvr/cvn292">10.1093/cvr/cvn292</ext-link></comment>
<pub-id pub-id-type="pmid">18977766</pub-id></mixed-citation></ref><ref id="pone.0183584.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Amulic</surname><given-names>B</given-names></name>, <name><surname>Cazalet</surname><given-names>C</given-names></name>, <name><surname>Hayes</surname><given-names>GL</given-names></name>, <name><surname>Metzler</surname><given-names>KD</given-names></name>, <name><surname>Zychlinsky</surname><given-names>A</given-names></name>. <article-title>Neutrophil function: from mechanisms to disease</article-title>. <source>Annu Rev Immunol</source>. <year>2012</year>; <volume>30</volume>: <fpage>459</fpage>&#x02013;<lpage>489</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev-immunol-020711-074942">10.1146/annurev-immunol-020711-074942</ext-link></comment>
<pub-id pub-id-type="pmid">22224774</pub-id></mixed-citation></ref><ref id="pone.0183584.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Ma</surname><given-names>Y</given-names></name>, <name><surname>Yabluchanskiy</surname><given-names>A</given-names></name>, <name><surname>Lindsey</surname><given-names>ML</given-names></name>. <article-title>Neutrophil roles in left ventricular remodeling following myocardial infarction</article-title>. <source>Fibrogenesis Tissue Repair</source>. <year>2013</year>; <volume>6</volume>: <fpage>11</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1755-1536-6-11">10.1186/1755-1536-6-11</ext-link></comment>
<pub-id pub-id-type="pmid">23731794</pub-id></mixed-citation></ref><ref id="pone.0183584.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Wan</surname><given-names>E</given-names></name>, <name><surname>Yeap</surname><given-names>XY</given-names></name>, <name><surname>Dehn</surname><given-names>S</given-names></name>, <name><surname>Terry</surname><given-names>R</given-names></name>, <name><surname>Novak</surname><given-names>M</given-names></name>, <name><surname>Zhang</surname><given-names>S</given-names></name>, <article-title>at al. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction</article-title>. <source>Circ Res</source>. <year>2013</year>; <volume>113</volume>: <fpage>1004</fpage>&#x02013;<lpage>1012</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCRESAHA.113.301198">10.1161/CIRCRESAHA.113.301198</ext-link></comment>
<pub-id pub-id-type="pmid">23836795</pub-id></mixed-citation></ref><ref id="pone.0183584.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>van Amerongen</surname><given-names>MJ</given-names></name>, <name><surname>Harmsen</surname><given-names>MC</given-names></name>, <name><surname>van Rooijen</surname><given-names>N</given-names></name>, <name><surname>Petersen</surname><given-names>AH</given-names></name>, <name><surname>van Luyn</surname><given-names>MJ</given-names></name>. <article-title>Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice</article-title>. <source>Am J Pathol</source>. <year>2007</year>; <volume>170</volume>: <fpage>818</fpage>&#x02013;<lpage>829</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2353/ajpath.2007.060547">10.2353/ajpath.2007.060547</ext-link></comment>
<pub-id pub-id-type="pmid">17322368</pub-id></mixed-citation></ref><ref id="pone.0183584.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Kumagai</surname><given-names>S</given-names></name>, <name><surname>Nakayama</surname><given-names>H</given-names></name>, <name><surname>Fujimoto</surname><given-names>M</given-names></name>, <name><surname>Honda</surname><given-names>H</given-names></name>, <name><surname>Serada</surname><given-names>S</given-names></name>, <name><surname>Ishibashi-Ueda</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Myeloid cell-derived LRG attenuates adverse cardiacremodelling after myocardial infarction</article-title>. <source>Cardiovasc Res</source>. <year>2016</year>; <volume>109</volume>: <fpage>272</fpage>&#x02013;<lpage>282</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/cvr/cvv273">10.1093/cvr/cvv273</ext-link></comment>
<pub-id pub-id-type="pmid">26678356</pub-id></mixed-citation></ref><ref id="pone.0183584.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>He</surname><given-names>YW</given-names></name>, <name><surname>Deftos</surname><given-names>ML</given-names></name>, <name><surname>Ojala</surname><given-names>EW</given-names></name>, <name><surname>Bevan</surname><given-names>MJ</given-names></name>. <article-title>ROR&#x003b3;t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells</article-title>. <source>Immunity</source>. <year>1998</year>; <volume>9</volume>: <fpage>797</fpage>&#x02013;<lpage>806</lpage>. <pub-id pub-id-type="pmid">9881970</pub-id></mixed-citation></ref><ref id="pone.0183584.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Ivanov</surname><given-names>II</given-names></name>, <name><surname>McKenzie</surname><given-names>BS</given-names></name>, <name><surname>Zhou</surname><given-names>L</given-names></name>, <name><surname>Tadokoro</surname><given-names>CE</given-names></name>, <name><surname>Lepelley</surname><given-names>A</given-names></name>, <name><surname>Lafaille</surname><given-names>JJ</given-names></name>, <etal>et al</etal>
<article-title>The orphan nuclear receptor ROR&#x003b3;t directs the differentiation program of proinflammatory IL-17<sup>+</sup> T helper cells</article-title>. <source>Cell</source>. <year>2006</year>; <volume>126</volume>: <fpage>1121</fpage>&#x02013;<lpage>1133</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2006.07.035">10.1016/j.cell.2006.07.035</ext-link></comment>
<pub-id pub-id-type="pmid">16990136</pub-id></mixed-citation></ref><ref id="pone.0183584.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Ishigame</surname><given-names>H</given-names></name>, <name><surname>Kakuta</surname><given-names>S</given-names></name>, <name><surname>Nagai</surname><given-names>T</given-names></name>, <name><surname>Kadoki</surname><given-names>M</given-names></name>, <name><surname>Nambu</surname><given-names>A</given-names></name>, <name><surname>Komiyama</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses</article-title>. <source>Immunity</source>. <year>2009</year>; <volume>30</volume>: <fpage>108</fpage>&#x02013;<lpage>119</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.immuni.2008.11.009">10.1016/j.immuni.2008.11.009</ext-link></comment>
<pub-id pub-id-type="pmid">19144317</pub-id></mixed-citation></ref><ref id="pone.0183584.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Mangan</surname><given-names>PR</given-names></name>, <name><surname>Harrington</surname><given-names>LE</given-names></name>, <name><surname>O'Quinn</surname><given-names>DB</given-names></name>, <name><surname>Helms</surname><given-names>WS</given-names></name>, <name><surname>Bullard</surname><given-names>DC</given-names></name>, <name><surname>Elson</surname><given-names>CO</given-names></name>, <etal>et al</etal>
<article-title>Transforming growth factor-&#x003b2; induces development of the T<sub>H</sub>17 lineage</article-title>. <source>Nature</source>. <year>2006</year>; <volume>441</volume>: <fpage>231</fpage>&#x02013;<lpage>234</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature04754">10.1038/nature04754</ext-link></comment>
<pub-id pub-id-type="pmid">16648837</pub-id></mixed-citation></ref><ref id="pone.0183584.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Sawa</surname><given-names>S</given-names></name>, <name><surname>Lochner</surname><given-names>M</given-names></name>, <name><surname>Satoh-Takayama</surname><given-names>N</given-names></name>, <name><surname>Dulauroy</surname><given-names>S</given-names></name>, <name><surname>B&#x000e9;rard</surname><given-names>M</given-names></name>, <name><surname>Kleinschek</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>ROR&#x003b3;t<sup>+</sup> innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota</article-title>. <source>Nat Immunol</source>. <year>2011</year>; <volume>4</volume>: <fpage>320</fpage>&#x02013;<lpage>326</lpage>.</mixed-citation></ref><ref id="pone.0183584.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Erbel</surname><given-names>C</given-names></name>, <name><surname>Akhavanpoor</surname><given-names>M</given-names></name>, <name><surname>Okuyucu</surname><given-names>D</given-names></name>, <name><surname>Wangler</surname><given-names>S</given-names></name>, <name><surname>Dietz</surname><given-names>A</given-names></name>, <name><surname>Zhao</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis</article-title>. <source>J Immunol</source>. <year>2014</year>; <volume>193</volume>: <fpage>4344</fpage>&#x02013;<lpage>4355</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4049/jimmunol.1400181">10.4049/jimmunol.1400181</ext-link></comment>
<pub-id pub-id-type="pmid">25261478</pub-id></mixed-citation></ref><ref id="pone.0183584.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>E</given-names></name>, <name><surname>Prasad</surname><given-names>KM</given-names></name>, <name><surname>Butcher</surname><given-names>M</given-names></name>, <name><surname>Dobrian</surname><given-names>A</given-names></name>, <name><surname>Kolls</surname><given-names>JK</given-names></name>, <name><surname>Ley</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Blockade of IL-17A results in reduced atherosclerosis in Apoe-deficient mice</article-title>. <source>Circulation</source>. <year>2010</year>; <volume>121</volume>: <fpage>1746</fpage>&#x02013;<lpage>1755</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCULATIONAHA.109.924886">10.1161/CIRCULATIONAHA.109.924886</ext-link></comment>
<pub-id pub-id-type="pmid">20368519</pub-id></mixed-citation></ref><ref id="pone.0183584.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Di Cesare</surname><given-names>A</given-names></name>, <name><surname>Di Meglio</surname><given-names>P</given-names></name>, <name><surname>Nestle</surname><given-names>FO</given-names></name>. <article-title>The IL-23/Th17 axis in the immunopathogenesis of psoriasis</article-title>. <source>J Invest Dermatol</source>. <year>2009</year>; <volume>129</volume>: <fpage>1339</fpage>&#x02013;<lpage>1350</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/jid.2009.59">10.1038/jid.2009.59</ext-link></comment>
<pub-id pub-id-type="pmid">19322214</pub-id></mixed-citation></ref><ref id="pone.0183584.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>van der Fits</surname><given-names>L</given-names></name>, <name><surname>Mourits</surname><given-names>S</given-names></name>, <name><surname>Voerman</surname><given-names>JS</given-names></name>, <name><surname>Kant</surname><given-names>M</given-names></name>, <name><surname>Boon</surname><given-names>L</given-names></name>, <name><surname>Laman</surname><given-names>JD</given-names></name>, <etal>et al</etal>
<article-title>Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis</article-title>. <source>J Immunol</source>. <year>2009</year>; <volume>182</volume>: <fpage>5836</fpage>&#x02013;<lpage>5845</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4049/jimmunol.0802999">10.4049/jimmunol.0802999</ext-link></comment>
<pub-id pub-id-type="pmid">19380832</pub-id></mixed-citation></ref><ref id="pone.0183584.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Waisman</surname><given-names>A</given-names></name>, <name><surname>Hauptmann</surname><given-names>J</given-names></name>, <name><surname>Regen</surname><given-names>T</given-names></name>. <article-title>The role of IL-17 in CNS diseases</article-title>. <source>Acta Neuropathol</source>. <year>2015</year>; <volume>129</volume>: <fpage>625</fpage>&#x02013;<lpage>637</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00401-015-1402-7">10.1007/s00401-015-1402-7</ext-link></comment>
<pub-id pub-id-type="pmid">25716179</pub-id></mixed-citation></ref><ref id="pone.0183584.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Benedetti</surname><given-names>G</given-names></name>, <name><surname>Miossec</surname><given-names>P</given-names></name>. <article-title>Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis</article-title>. <source>Eur J Immunol</source>. <year>2014</year>; <volume>44</volume>: <fpage>339</fpage>&#x02013;<lpage>347</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/eji.201344184">10.1002/eji.201344184</ext-link></comment>
<pub-id pub-id-type="pmid">24310226</pub-id></mixed-citation></ref><ref id="pone.0183584.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Yan</surname><given-names>X</given-names></name>, <name><surname>Shichita</surname><given-names>T</given-names></name>, <name><surname>Katsumata</surname><given-names>Y</given-names></name>, <name><surname>Matsuhashi</surname><given-names>T</given-names></name>, <name><surname>Ito</surname><given-names>H</given-names></name>, <name><surname>Ito</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Deleterious effect of the IL-23/IL-17A axis and &#x003b3;&#x003b4;T cells on left ventricular remodeling after myocardial infarction</article-title>. <source>J Am Heart Assoc</source>. <year>2012</year>; <volume>5</volume>: <fpage>e004408</fpage>.</mixed-citation></ref><ref id="pone.0183584.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>SF</given-names></name>, <name><surname>Yuan</surname><given-names>J</given-names></name>, <name><surname>Liao</surname><given-names>MY</given-names></name>, <name><surname>Xia</surname><given-names>N</given-names></name>, <name><surname>Tang</surname><given-names>TT</given-names></name>, <name><surname>Li</surname><given-names>JJ</given-names></name>, <etal>et al</etal>
<article-title>IL-17A promotes ventricular remodeling after myocardial infarction</article-title>. <source>J Mol Med</source>. <year>2014</year>; <volume>92</volume>: <fpage>1105</fpage>&#x02013;<lpage>1116</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00109-014-1176-8">10.1007/s00109-014-1176-8</ext-link></comment>
<pub-id pub-id-type="pmid">24965614</pub-id></mixed-citation></ref><ref id="pone.0183584.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Skepner</surname><given-names>J</given-names></name>, <name><surname>Ramesh</surname><given-names>R</given-names></name>, <name><surname>Trocha</surname><given-names>M</given-names></name>, <name><surname>Schmidt</surname><given-names>D</given-names></name>, <name><surname>Baloglu</surname><given-names>E</given-names></name>, <name><surname>Lobera</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Pharmacologic inhibition of ROR&#x003b3;t regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo</article-title>. <source>J Immunol</source>. <year>2014</year>; <volume>192</volume>: <fpage>2564</fpage>&#x02013;<lpage>2575</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4049/jimmunol.1302190">10.4049/jimmunol.1302190</ext-link></comment>
<pub-id pub-id-type="pmid">24516202</pub-id></mixed-citation></ref><ref id="pone.0183584.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Banerjee</surname><given-names>D</given-names></name>, <name><surname>Zhao</surname><given-names>L</given-names></name>, <name><surname>Wu</surname><given-names>L</given-names></name>, <name><surname>Palanichamy</surname><given-names>A</given-names></name>, <name><surname>Ergun</surname><given-names>A</given-names></name>, <name><surname>Peng</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Small molecule mediated inhibition of ROR&#x003b3;-dependent gene expression and autoimmune disease pathology in vivo</article-title>. <source>Immunology</source>. <year>2016</year>; <volume>147</volume>: <fpage>399</fpage>&#x02013;<lpage>413</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/imm.12570">10.1111/imm.12570</ext-link></comment>
<pub-id pub-id-type="pmid">26694902</pub-id></mixed-citation></ref><ref id="pone.0183584.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Obana</surname><given-names>M</given-names></name>, <name><surname>Maeda</surname><given-names>M</given-names></name>, <name><surname>Takeda</surname><given-names>K</given-names></name>, <name><surname>Hayama</surname><given-names>A</given-names></name>, <name><surname>Mohri</surname><given-names>T</given-names></name>, <name><surname>Yamashita</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction</article-title>. <source>Circulation</source>. <year>2010</year>; <volume>121</volume>: <fpage>684</fpage>&#x02013;<lpage>691</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCULATIONAHA.109.893677">10.1161/CIRCULATIONAHA.109.893677</ext-link></comment>
<pub-id pub-id-type="pmid">20100971</pub-id></mixed-citation></ref><ref id="pone.0183584.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Enomoto</surname><given-names>D</given-names></name>, <name><surname>Obana</surname><given-names>M</given-names></name>, <name><surname>Miyawaki</surname><given-names>A</given-names></name>, <name><surname>Maeda</surname><given-names>M</given-names></name>, <name><surname>Nakayama</surname><given-names>H</given-names></name>, <name><surname>Fujio</surname><given-names>Y</given-names></name>. <article-title>Cardiac-specific ablation of the STAT3 gene in the subacute phase of myocardial infarction exacerbated cardiac remodeling</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2015</year>; <volume>309</volume>: <fpage>H471</fpage>&#x02013;<lpage>480</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpheart.00730.2014">10.1152/ajpheart.00730.2014</ext-link></comment>
<pub-id pub-id-type="pmid">26055795</pub-id></mixed-citation></ref><ref id="pone.0183584.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Takagawa</surname><given-names>J</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Wong</surname><given-names>ML</given-names></name>, <name><surname>Sievers</surname><given-names>RE</given-names></name>, <name><surname>Kapasi</surname><given-names>NK</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches</article-title>. <source>J Appl Physiol (1985)</source>. <year>2007</year>; <volume>102</volume>: <fpage>2104</fpage>&#x02013;<lpage>2111</lpage>.<pub-id pub-id-type="pmid">17347379</pub-id></mixed-citation></ref><ref id="pone.0183584.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Yamashita</surname><given-names>T</given-names></name>, <name><surname>Iwakura</surname><given-names>T</given-names></name>, <name><surname>Matsui</surname><given-names>K</given-names></name>, <name><surname>Kawaguchi</surname><given-names>H</given-names></name>, <name><surname>Obana</surname><given-names>M</given-names></name>, <name><surname>Hayama</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>IL-6-mediated Th17 differentiation through ROR&#x003b3;t is essential for the initiation of experimental autoimmune myocarditis</article-title>. <source>Cardiovasc Res</source>. <year>2011</year>; <volume>91</volume>: <fpage>640</fpage>&#x02013;<lpage>648</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/cvr/cvr148">10.1093/cvr/cvr148</ext-link></comment>
<pub-id pub-id-type="pmid">21622681</pub-id></mixed-citation></ref><ref id="pone.0183584.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Maisel</surname><given-names>A</given-names></name>, <name><surname>Cesario</surname><given-names>D</given-names></name>, <name><surname>Baird</surname><given-names>S</given-names></name>, <name><surname>Rehman</surname><given-names>J</given-names></name>, <name><surname>Haghighi</surname><given-names>P</given-names></name>, <name><surname>Carter</surname><given-names>S</given-names></name>. <article-title>Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after myocardial infarction</article-title>. <source>Circ Res</source>. <year>1998</year>; <volume>82</volume>: <fpage>458</fpage>&#x02013;<lpage>463</lpage>. <pub-id pub-id-type="pmid">9506706</pub-id></mixed-citation></ref><ref id="pone.0183584.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Giordano</surname><given-names>FJ</given-names></name>, <name><surname>Gerber</surname><given-names>HP</given-names></name>, <name><surname>Williams</surname><given-names>SP</given-names></name>, <name><surname>VanBruggen</surname><given-names>N</given-names></name>, <name><surname>Bunting</surname><given-names>S</given-names></name>, <name><surname>Ruiz-Lozano</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2001</year>; <volume>98</volume>: <fpage>5780</fpage>&#x02013;<lpage>5785</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.091415198">10.1073/pnas.091415198</ext-link></comment>
<pub-id pub-id-type="pmid">11331753</pub-id></mixed-citation></ref><ref id="pone.0183584.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Shujia</surname><given-names>J</given-names></name>, <name><surname>Haider</surname><given-names>HK</given-names></name>, <name><surname>Idris</surname><given-names>NM</given-names></name>, <name><surname>Lu</surname><given-names>G</given-names></name>, <name><surname>Ashraf</surname><given-names>M</given-names></name>. <article-title>Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair</article-title>. <source>Cardiovasc Res</source>. <year>2008</year>; <volume>77</volume>: <fpage>525</fpage>&#x02013;<lpage>533</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/cvr/cvm077">10.1093/cvr/cvm077</ext-link></comment>
<pub-id pub-id-type="pmid">18032392</pub-id></mixed-citation></ref><ref id="pone.0183584.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Timmers</surname><given-names>L</given-names></name>, <name><surname>Sluijter</surname><given-names>JP</given-names></name>, <name><surname>van Keulen</surname><given-names>JK</given-names></name>, <name><surname>Hoefer</surname><given-names>IE</given-names></name>, <name><surname>Nederhoff</surname><given-names>MG</given-names></name>, <name><surname>Goumans</surname><given-names>MJ</given-names></name>, <etal>et al</etal>
<article-title>Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction</article-title>. <source>Circ Res</source>. <year>2008</year>; <volume>102</volume>: <fpage>257</fpage>&#x02013;<lpage>264</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCRESAHA.107.158220">10.1161/CIRCRESAHA.107.158220</ext-link></comment>
<pub-id pub-id-type="pmid">18007026</pub-id></mixed-citation></ref><ref id="pone.0183584.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Avalos</surname><given-names>AM</given-names></name>, <name><surname>Apablaza</surname><given-names>FA</given-names></name>, <name><surname>Quiroz</surname><given-names>M</given-names></name>, <name><surname>Toledo</surname><given-names>V</given-names></name>, <name><surname>Pena</surname><given-names>JP</given-names></name>, <name><surname>Michea</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>IL-17A levels increase in the infarcted region of the left ventricle in a rat model of myocardial infarction</article-title>. <source>Biol Res</source>. <year>2012</year>, <volume>45</volume>:<fpage>193</fpage>&#x02013;<lpage>200</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4067/S0716-97602012000200012">10.4067/S0716-97602012000200012</ext-link></comment>
<pub-id pub-id-type="pmid">23096364</pub-id></mixed-citation></ref><ref id="pone.0183584.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Vantourout</surname><given-names>P</given-names></name>, <name><surname>Hayday</surname><given-names>A</given-names></name>. <article-title>Six-of-the-best: unique contributions of &#x003b3;&#x003b4; T cells to immunology</article-title>. <source>Nat Rev Immunol</source>. <year>2013</year>; <volume>13</volume>: <fpage>88</fpage>&#x02013;<lpage>100</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nri3384">10.1038/nri3384</ext-link></comment>
<pub-id pub-id-type="pmid">23348415</pub-id></mixed-citation></ref><ref id="pone.0183584.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Rao</surname><given-names>R</given-names></name>, <name><surname>Graffeo</surname><given-names>CS</given-names></name>, <name><surname>Gulati</surname><given-names>R</given-names></name>, <name><surname>Jamal</surname><given-names>M</given-names></name>, <name><surname>Narayan</surname><given-names>S</given-names></name>, <name><surname>Zambirinis</surname><given-names>CP</given-names></name>, <etal>et al</etal>
<article-title>Interleukin 17-producing &#x003b3;&#x003b4;T cells promote hepatic regeneration in mice</article-title>. <source>Gastroenterology</source>. <year>2014</year>; <volume>147</volume>: <fpage>473</fpage>&#x02013;<lpage>484</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/j.gastro.2014.04.042">10.1053/j.gastro.2014.04.042</ext-link></comment>
<pub-id pub-id-type="pmid">24801349</pub-id></mixed-citation></ref><ref id="pone.0183584.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Ono</surname><given-names>T</given-names></name>, <name><surname>Okamoto</surname><given-names>K</given-names></name>, <name><surname>Nakashima</surname><given-names>T</given-names></name>, <name><surname>Nitta</surname><given-names>T</given-names></name>, <name><surname>Hori</surname><given-names>S</given-names></name>, <name><surname>Iwakura</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>IL-17-producing &#x003b3;&#x003b4; T cells enhance bone regeneration</article-title>. <source>Nat Commun</source>. <year>2016</year>; <volume>7</volume>: <fpage>10928</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncomms10928">10.1038/ncomms10928</ext-link></comment>
<pub-id pub-id-type="pmid">26965320</pub-id></mixed-citation></ref><ref id="pone.0183584.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Ahn</surname><given-names>SH</given-names></name>, <name><surname>Edwards</surname><given-names>AK</given-names></name>, <name><surname>Singh</surname><given-names>SS</given-names></name>, <name><surname>Young</surname><given-names>SL</given-names></name>, <name><surname>Lessey</surname><given-names>BA</given-names></name>, <name><surname>Tayade</surname><given-names>C</given-names></name>. <article-title>IL-17A Contributes to the Pathogenesis of Endometriosis by Triggering Proinflammatory Cytokines and Angiogenic Growth Factors</article-title>. <source>J Immunol</source>. <year>2015</year>; <volume>195</volume>: <fpage>2591</fpage>&#x02013;<lpage>2600</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4049/jimmunol.1501138">10.4049/jimmunol.1501138</ext-link></comment>
<pub-id pub-id-type="pmid">26259585</pub-id></mixed-citation></ref><ref id="pone.0183584.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Wakita</surname><given-names>D</given-names></name>, <name><surname>Sumida</surname><given-names>K</given-names></name>, <name><surname>Iwakura</surname><given-names>Y</given-names></name>, <name><surname>Nishikawa</surname><given-names>H</given-names></name>, <name><surname>Ohkuri</surname><given-names>T</given-names></name>, <name><surname>Chamoto</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Tumor-infiltrating IL-17-producing &#x003b3;&#x003b4; T cells support the progression of tumor by promoting angiogenesis</article-title>. <source>Eur J Immunol</source>. <year>2010</year>; <volume>40</volume>: <fpage>1927</fpage>&#x02013;<lpage>1937</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/eji.200940157">10.1002/eji.200940157</ext-link></comment>
<pub-id pub-id-type="pmid">20397212</pub-id></mixed-citation></ref><ref id="pone.0183584.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>MacMillan</surname><given-names>CJ</given-names></name>, <name><surname>Furlong</surname><given-names>SJ</given-names></name>, <name><surname>Doucette</surname><given-names>CD</given-names></name>, <name><surname>Chen</surname><given-names>PL</given-names></name>, <name><surname>Hoskin</surname><given-names>DW</given-names></name>, <article-title>Easton AS: Bevacizumab diminishes experimental autoimmune encephalomyelitis by inhibiting spinal cord angiogenesis and reducing peripheral T-cell responses</article-title>. <source>J Neuropathol Exp Neurol</source>. <year>2012</year>; <volume>71</volume>: <fpage>983</fpage>&#x02013;<lpage>999</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/NEN.0b013e3182724831">10.1097/NEN.0b013e3182724831</ext-link></comment>
<pub-id pub-id-type="pmid">23037326</pub-id></mixed-citation></ref><ref id="pone.0183584.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Root-Bernstein</surname><given-names>R</given-names></name>, <name><surname>Fairweather</surname><given-names>D</given-names></name>. <article-title>Unresolved issues in theories of autoimmune disease using myocarditis as a framework</article-title>. <source>J Theor Biol</source>. <year>2015</year>; <volume>375</volume>: <fpage>101</fpage>&#x02013;<lpage>123</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jtbi.2014.11.022">10.1016/j.jtbi.2014.11.022</ext-link></comment>
<pub-id pub-id-type="pmid">25484004</pub-id></mixed-citation></ref></ref-list></back></article>